Page last updated: 2024-09-04

bz-423 and Severe Combined Immunodeficiency

bz-423 has been researched along with Severe Combined Immunodeficiency in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aslam, MN; Bhagavathula, N; Glick, GD; Hanosh, A; Johnson, K; Kang, S; Nerusu, KC; Opipari, AW; Sundberg, TB; Varani, J1

Other Studies

1 other study(ies) available for bz-423 and Severe Combined Immunodeficiency

ArticleYear
7-Chloro-5-(4-hydroxyphenyl)-1-methyl-3-(naphthalen-2-ylmethyl)-4,5-dihydro-1H-benzo[b][1,4]diazepin-2(3H)-one (Bz-423), a benzodiazepine, suppresses keratinocyte proliferation and has antipsoriatic activity in the human skin-severe, combined immunodefici
    The Journal of pharmacology and experimental therapeutics, 2008, Volume: 324, Issue:3

    Topics: Animals; Benzodiazepines; Cell Proliferation; Disease Models, Animal; Humans; Keratinocytes; Mice; Mice, SCID; Psoriasis; Severe Combined Immunodeficiency; Skin Transplantation

2008